Latest News

Amino acid offers potential therapeutic alternative in psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Public Health Responsibility Deal in UK unlikely to be an effective response to alcohol harms

  • Immunotherapy used to reduce memory problems with Alzheimer's disease

  • How the brain 'remembers' pain

  • Calcium channels play a role in neuronal homeostasis, elimination of toxic buildup of proteins

  • Love the cook, love the food: Attraction to comfort food linked to positive social connections

  • Intergenerational transmission of abuse and neglect more complicated than previously believed

  • Researchers identify timeline for HIV replication in the brain

  • New autism-causing genetic variant identified

  • The brain in the supermarket: Index strategy informs decision-making

  • Boredom can be good for you, scientists say

  •